Example 3
The lactic acid buffer solution was added to the gelatin to dissolve the gelatin therein. The in-vivo intravascular blood replacing liquid (flush solution) was prepared by adjusting the concentration of the gelatin to 4 mg/mL. The viscosity of the flush solution at 25 degrees C. was 1.1 mPa·s.
The lactic acid buffer solution was added to the weighed amount of the glycyrrhizin acid monoammonium to prepare a solution of 0.20 mg/mL. In this manner, the flush solution was obtained. The viscosity of the flush solution at 25 degrees C. was 1.0 mPa·s.
By adding 5 g of the polyvinylpyrrolidone (produced by Sigma-Aldrich Corporation) having a molecular weight of 40,000 to 50 g of the RO water and dissolving the polyvinylpyrrolidone in the RO water, the in-vivo intravascular blood replacing liquid (reference example 3) of the present invention was formed. The viscosity of the in-vivo intravascular blood replacing liquid of the reference example 3 was 7.7 mPa·s.